4.5 Review

Questions and Answers on the Role of Fecal Lactoferrin as a Biological Marker in Inflammatory Bowel Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

J. P. Gisbert et al.

DIGESTIVE AND LIVER DISEASE (2009)

Article Gastroenterology & Hepatology

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

T. Sipponen et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)

Article Gastroenterology & Hepatology

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

Jennifer Jones et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Review Gastroenterology & Hepatology

Review of fecal biomarkers in inflammatory bowel disease

Andrew D. Sutherland et al.

DISEASES OF THE COLON & RECTUM (2008)

Article Gastroenterology & Hepatology

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

Alain M. Schoepfer et al.

INFLAMMATORY BOWEL DISEASES (2008)

Article Gastroenterology & Hepatology

Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease

Taina Sipponen et al.

INFLAMMATORY BOWEL DISEASES (2008)

Article Gastroenterology & Hepatology

Cost-effectiveness of quantitative fecal lactoferrin assay for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

Mansour A. Parsi et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Accuracy of four fecal assays in the diagnosis of colitis

Alain M. Schoepfer et al.

DISEASES OF THE COLON & RECTUM (2007)

Article Gastroenterology & Hepatology

Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease

Marco Scarpa et al.

DISEASES OF THE COLON & RECTUM (2007)

Article Medical Laboratory Technology

Enzymes in feces: Useful markers of chronic inflammatory bowel disease

Imerio Angriman et al.

CLINICA CHIMICA ACTA (2007)

Article Gastroenterology & Hepatology

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

Renata D'Inca et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)

Article Gastroenterology & Hepatology

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

Paul Rutgeerts et al.

Article Gastroenterology & Hepatology

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

Alexander C. von Roon et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Relationship between fecal lactoferrin and inflammatory bowel disease

Jun Dai et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease

Thomas R. Walker et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)

Review Gastroenterology & Hepatology

Oratory markers in IBD: Magic, or unneccessary toys?

S Vermeire et al.

Article Gastroenterology & Hepatology

Combined use of Noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease

RB Canani et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)

Review Gastroenterology & Hepatology

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

Michael R. Konikoff et al.

INFLAMMATORY BOWEL DISEASES (2006)

Review Gastroenterology & Hepatology

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

S Vermeire et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis

J Langhorst et al.

INFLAMMATORY BOWEL DISEASES (2005)

Review Gastroenterology & Hepatology

Technology insight:: Calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease

J Lundberg et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

P Rutgeerts et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

M Daperno et al.

GASTROINTESTINAL ENDOSCOPY (2004)

Review Gastroenterology & Hepatology

C-reactive protein as a marker for inflammatory bowel disease

S Vermeire et al.

INFLAMMATORY BOWEL DISEASES (2004)

Article Gastroenterology & Hepatology

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

RB Canani et al.

DIGESTIVE AND LIVER DISEASE (2004)

Article Gastroenterology & Hepatology

Fecal lactoferrin: A new parameter to monitor infliximab therapy

S Buderus et al.

DIGESTIVE DISEASES AND SCIENCES (2004)

Article Gastroenterology & Hepatology

Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

MA Parsi et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Fecal calprotectin levels in healthy children studied with an improved assay

UL Fagerberg et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)

Article Gastroenterology & Hepatology

Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease

IDR Arnott et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)

Article Gastroenterology & Hepatology

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

A Poullis et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)

Article Gastroenterology & Hepatology

A simple method for assessing intestinal inflammation in Crohn's disease

J Tibble et al.